The increased incidence of prostate cancer is interesting in view of involvement of BRCA2/FANCD1 in the FA gene pathway; male BRCA2 carriers have an increased risk of prostate cancer [14] so there is a theoretical molecular link. This evidence concerns the gene FANCA and prostate carcinoma.